five

Supplementary Table 1. Disseminated adenovirus infection in a patient with a hematologic malignancy: a case report and literature reviewDisseminated adenovirus infection in a patient with a hematologic malignancy: a case report and literature review

收藏
DataCite Commons2024-05-17 更新2025-04-15 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Supplementary_Table_1_Disseminated_adenovirus_infection_in_a_patient_with_a_hematologic_malignancy_a_case_report_and_literature_reviewDisseminated_adenovirus_infection_in_a_patient_with_a_hematologic_malignancy_a_case_report_and_literature_/9741623/1
下载链接
链接失效反馈
官方服务:
资源简介:
<b>Supplementary Table 1</b>. Disseminated adenovirus infection in a patient with a hematologic malignancy: a case report and literature review<br>AbstractHuman adenoviruses (HAdVs) cause a wide spectrum of illnesses, including invasive infections, in immunocompromised hosts. We report a case of disseminated adenovirus infection following unrelated cord-blood transplantation in a 46-year-old male with a lymphoma. A review of the literature on disseminated adenovirus infections in adult patients with hematopoietic stem cell transplantation (HSCT) has also been included. Despite antiviral therapy, the mortality rate in HSCT recipients with a disseminated adenovirus infection is as high as 72%, and estimating the risk of HAdV infection in a timely manner is crucial to improving outcomes.<br><br> <br><br> Supplementary Table 1. Disseminated adenovirus infection in a patient with a hematologic malignancy: a case report and literature review<br>Supplementary Table 2. Disseminated adenovirus infection in a patient with a hematologic malignancy: a case report and literature review<br>AbstractHuman adenoviruses (HAdVs) cause a wide spectrum of illnesses, including invasive infections, in immunocompromised hosts. We report a case of disseminated adenovirus infection following unrelated cord-blood transplantation in a 46-year-old male with a lymphoma. A review of the literature on disseminated adenovirus infections in adult patients with hematopoietic stem cell transplantation (HSCT) has also been included. Despite antiviral therapy, the mortality rate in HSCT recipients with a disseminated adenovirus infection is as high as 72%, and estimating the risk of HAdV infection in a timely manner is crucial to improving outcomes.<br>

**补充表1** 造血系统恶性肿瘤患者播散性腺病毒感染:1例病例报告及文献综述<br>摘要 人类腺病毒(Human adenoviruses, HAdVs)可在免疫功能低下宿主中引发多种疾病,包括侵袭性感染。本文报告1例46岁男性淋巴瘤患者接受非亲缘脐带血移植后并发播散性腺病毒感染的病例,并综述了成人造血干细胞移植(hematopoietic stem cell transplantation, HSCT)患者并发播散性腺病毒感染的相关文献。尽管接受抗病毒治疗,造血干细胞移植受者合并播散性腺病毒感染的死亡率仍高达72%,及时评估人类腺病毒感染风险对改善患者预后至关重要。<br><br>**补充表1** 造血系统恶性肿瘤患者播散性腺病毒感染:1例病例报告及文献综述<br>**补充表2** 造血系统恶性肿瘤患者播散性腺病毒感染:1例病例报告及文献综述<br>摘要 人类腺病毒(Human adenoviruses, HAdVs)可在免疫功能低下宿主中引发多种疾病,包括侵袭性感染。本文报告1例46岁男性淋巴瘤患者接受非亲缘脐带血移植后并发播散性腺病毒感染的病例,并综述了成人造血干细胞移植(hematopoietic stem cell transplantation, HSCT)患者并发播散性腺病毒感染的相关文献。尽管接受抗病毒治疗,造血干细胞移植受者合并播散性腺病毒感染的死亡率仍高达72%,及时评估人类腺病毒感染风险对改善患者预后至关重要。<br>
提供机构:
Taylor & Francis
创建时间:
2019-08-28
二维码
社区交流群
二维码
科研交流群
商业服务